<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04034433</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0215</org_study_id>
    <secondary_id>ID-RCB</secondary_id>
    <nct_id>NCT04034433</nct_id>
  </id_info>
  <brief_title>Exercise Program for Arteriovenous Fistula Maturation</brief_title>
  <acronym>FAVULOUS</acronym>
  <official_title>Benefits of a Perioperative Exercise Program on Maturation of Dialysis Arteriovenous Fistulas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arteriovenous fistula (AVF) is the recommended vascular access for chronic hemodialysis, as
      it is associated with less mortality and better patency than arteriovenous graft (AVG) or
      central venous catheter (CVC).

      Unfortunately, AVF suffers from a high failure rate, due, in part, to poor venous diameter.

      The aim of this study is to investigate whether a perioperative handgrip training can improve
      the diameter of AVF in patients with chronic kidney disease (CKD) (stage IV-V).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 30, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arteriovenous Fistula (AVF diameter)</measure>
    <time_frame>at 6 weeks (after surgery)</time_frame>
    <description>Arteriovenous Fistula diameter will be measured by Doppler ultrasound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echographic maturation rate</measure>
    <time_frame>at 6 weeks (after surgery)</time_frame>
    <description>Maturation rate of Arteriovenous Fistula (AVF) by echography defined as blood flow&gt;600milliLiters/minute (mL/min), diameter&gt;6millimeters (mm) and depth &lt;6mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical maturation rate</measure>
    <time_frame>at 6 weeks (after surgery)</time_frame>
    <description>Arteriovenous Fistula (AVF) measured by a vein easily palpable, relatively straight, with a uniform sensation of quivering and more than 10centimeters (cm) long.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arteriovenous Fistula (AVF) localization (arm or forearm)</measure>
    <time_frame>at 6 weeks (after surgery)</time_frame>
    <description>After the patient's examination, the vascular surgeon will choose the future AVF localization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arteriovenous Fistula (AVF) interventions</measure>
    <time_frame>up to 6 weeks</time_frame>
    <description>Necessity of performing an intervention (such as angioplasty or thrombolysis or thrombectomy or superficialization) on the Arteriovenous Fistula (AVF)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency hemodialysis on Central Venous Catheter (CVC)</measure>
    <time_frame>up to 6 weeks</time_frame>
    <description>Necessity of patients on CVC to undergo emergency hemodialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency hemodialysis on Arteriovenous Graft (AVG)</measure>
    <time_frame>up to 6 weeks</time_frame>
    <description>Necessity of patients on AVG to undergo emergency hemodialysis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Arteriovenous Fistula</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Handgrip exercise program</intervention_name>
    <description>Handgrip exercise with a rubber ball 4 weeks before the surgery until 4 weeks after the surgery 20 contractions per minute for a total of 20 minutes each day.</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years

          -  with chronic kidney disease (Estimated Glomerular Filtration Rate (eGFR) &lt;30
             milliLiter/minute (mL/min))

          -  with follow-up at the University Hospital of Lyon Sud

          -  who choose hemodialysis as renal replacement therapy

        Exclusion Criteria:

          -  contraindication for arteriovenous fistula (AVF) surgery

          -  refusing AVF creation

          -  prior vascular access

          -  antecedent of IV substance abuse

          -  active cancer

          -  inability to perform handgrip exercise

          -  physical or mental disability limiting follow-up possibility

          -  inclusion in an other interventional study

          -  no social welfare
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abbas DEEB, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abbas DEEB, PhD</last_name>
    <phone>04.72.67.87.03</phone>
    <phone_ext>33</phone_ext>
    <email>abbas.deeb@chu-lyon.fr</email>
  </overall_contact>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 24, 2019</study_first_submitted>
  <study_first_submitted_qc>July 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2019</study_first_posted>
  <last_update_submitted>July 25, 2019</last_update_submitted>
  <last_update_submitted_qc>July 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arteriovenous Fistula Diameter</keyword>
  <keyword>Handgrip</keyword>
  <keyword>Program exercise</keyword>
  <keyword>Maturation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

